新型疗法治疗复发/难治性大 B 细胞淋巴瘤。
New Treatment for Relapsed or Refractory Large B-cell lymphoma.
机构信息
Diane S. Aschenbrenner is an assistant professor at Notre Dame of Maryland University in Baltimore. She also coordinates Drug Watch :
出版信息
Am J Nurs. 2021 Jun 1;121(6):21-22. doi: 10.1097/01.NAJ.0000753644.07326.f6.
Abstract
Lisocabtagene maraleucel (Breyanzi), a personalized cell-based gene therapy, has been approved to treat adults with various relapsed or refractory large B-cell lymphomas.
摘要
利妥昔单抗注射用冻干粉（倍利妥），一种个体化细胞基因治疗药物，已获批用于治疗多种复发/难治性大 B 细胞淋巴瘤的成人患者。
Zotero 插件